Common birth control drugs may Increases risk of HIV:
As we can see common birth control drugs may risk up HIV, we are going to discuss it’s probable causes. The Human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) which causes HIV infection.
Over time Acquired Immuno Deficiency Syndrome (AIDS)(birth), AIDS is also a condition in humans which results in progressive failure of the immune system. It thereby allows life-threatening opportunistic infections and thereby cancers to thrive.
Johannesburg, Jan 5 (PTI): A popular injectable contraceptive drug may significantly increase the risk of HIV infection, the study claims.
Depot-medroxyprogesterone acetate (DMPA) – a birth control shot administered every three months – is the predominant contraceptive in Sub-Saharan Africa, researchers said. In 2015,
India had thereby approved the use of DMPA and recommended its inclusion in the national family planning programme. It thus administered free of cost once every three months, usually on the upper arm or the buttocks.
A study has thus recently warned that a popular injectable contraceptive drug can increase the risk of HIV infection in women by 40 percent. Depot-medroxyprogesterone acetate (DMPA) is an injectable birth control shot administered every three months, which thereby prevents the ovaries from releasing eggs. It thereby thickens the mucous layer around the cervix to block sperm from getting through.
According to researchers, transitioning away from DMPA could thereby help protect women from becoming infected with HIV. Human studies thus suggest DMPA use may raise the risk of HIV infection by 40 percent.
Charu Kaushic, McMaster University, Hamilton, Ontario, Canada, thereby examined the underlying biological mechanisms that could contribute to increased risk of HIV infection for certain hormonal contraceptives but not others.
“To protect individual and public health, it is thereby important to ensure women in areas with high rates of HIV infection have access to affordable contraceptive options,” Hap good said.
“Increasing availability of contraceptives that use a form of the female hormone progestin is thus different from the one found in DMPA could, therefore, help reduce the risk of HIV transmission.”